TR200002973T2 - Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi - Google Patents
Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesiInfo
- Publication number
- TR200002973T2 TR200002973T2 TR2000/02973T TR200002973T TR200002973T2 TR 200002973 T2 TR200002973 T2 TR 200002973T2 TR 2000/02973 T TR2000/02973 T TR 2000/02973T TR 200002973 T TR200002973 T TR 200002973T TR 200002973 T2 TR200002973 T2 TR 200002973T2
- Authority
- TR
- Turkey
- Prior art keywords
- inflammatory diseases
- heat shock
- treating inflammatory
- shock proteins
- mammal
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 title 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010014950 Eosinophilia Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004043 responsiveness Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233098A | 1998-01-23 | 1998-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200002973T2 true TR200002973T2 (tr) | 2001-02-21 |
Family
ID=21754459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/02973T TR200002973T2 (tr) | 1998-01-23 | 1999-01-22 | Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20020006410A1 (https=) |
| EP (1) | EP1049483A1 (https=) |
| JP (1) | JP2002509074A (https=) |
| KR (1) | KR20010040389A (https=) |
| CN (1) | CN1324243A (https=) |
| AU (1) | AU2337499A (https=) |
| BR (1) | BR9907228A (https=) |
| CA (1) | CA2318263A1 (https=) |
| CZ (1) | CZ20002669A3 (https=) |
| HU (1) | HUP0100241A2 (https=) |
| IL (1) | IL137404A0 (https=) |
| NO (1) | NO20003775L (https=) |
| PL (1) | PL342166A1 (https=) |
| TR (1) | TR200002973T2 (https=) |
| WO (1) | WO1999037319A1 (https=) |
| ZA (1) | ZA99499B (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
| AU3239400A (en) * | 1999-02-22 | 2000-09-04 | University Of Iowa Research Foundation, The | Method for inhibiting inflammatory responses |
| WO2001022816A1 (en) * | 1999-09-30 | 2001-04-05 | National Jewish Medical And Research Center | MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| US6737398B1 (en) | 1999-09-30 | 2004-05-18 | National Jewish Medical And Research Center | Modulation of γδ T cells to regulate airway hyperresponsiveness |
| US7235649B2 (en) * | 2000-03-24 | 2007-06-26 | Duke University | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| AUPR381601A0 (en) * | 2001-03-19 | 2001-04-12 | Monash University | Method of treating respiratory conditions |
| EP1551957A4 (en) * | 2001-10-01 | 2007-01-24 | Univ Duke | ISOLATED POLYPEPTIDE OF THE GRP94 LIGANDEN BINDING DOMAIN AND NUCLEIC ACID, CRYSTALLINE FORM THEREOF, CODING THEREOF, AND SCRAPPING METHOD WHERE IT IS USED |
| WO2003068941A2 (en) * | 2002-02-13 | 2003-08-21 | Duke University | Modulation of immune response by non-peptide binding stress response polypeptides |
| KR100615389B1 (ko) * | 2002-08-23 | 2006-08-25 | (주)헬릭서 | 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품 |
| US20100111927A1 (en) * | 2002-08-23 | 2010-05-06 | Sunyoung Kim | Compositions Comprising Actinidia and Methods of Use Thereof |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| CN101330922A (zh) * | 2005-10-20 | 2008-12-24 | 悉生物有限公司 | 超敏的治疗 |
| KR100768265B1 (ko) * | 2005-11-10 | 2007-10-17 | 한국화학연구원 | 혈액내 순환시간을 향상시키기 위한 헤파린이 수식된리포솜 및 이의 제조방법 |
| AU2009262670B2 (en) | 2008-06-26 | 2013-06-20 | Zevra Denmark A/S | Use of Hsp70 as a regulator of enzymatic activity |
| WO2010086418A1 (en) * | 2009-01-29 | 2010-08-05 | Alfa Biogene International B.V. | Functional food product comprising heat shock protein or a hydrolysate thereof |
| EP2397074B1 (en) | 2010-06-19 | 2012-10-24 | M Stenqvist AB | A system and computer readable medium for determination of transpulmonary pressure in a patient connected to a breathing apparatus |
| CA2817773A1 (en) | 2010-11-30 | 2012-06-07 | Orphazyme Aps | Methods for increasing intracellular activity of hsp70 |
| WO2012097255A2 (en) * | 2011-01-14 | 2012-07-19 | Scott & White Healthcare | Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus |
| DK2707101T3 (da) | 2011-05-12 | 2019-05-13 | Proteostasis Therapeutics Inc | Proteostaseregulatorer |
| US20140228315A1 (en) * | 2011-06-16 | 2014-08-14 | Children's Hospital Medical Center | Blockade of eosinophil production by toll-like receptors |
| US10034915B2 (en) | 2011-06-23 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia |
| CA2861464C (en) | 2012-01-25 | 2018-03-06 | Proteostasis Therapeutics, Inc. | Proteasome activity modulating tricyclic compounds |
| AU2015317447B2 (en) | 2014-09-15 | 2021-02-25 | Zevra Denmark A/S | Arimoclomol formulation |
| EP3402572B1 (en) | 2016-01-13 | 2022-03-16 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| DK3782624T3 (da) | 2016-04-29 | 2025-12-15 | Zevra Denmark As | Arimoclomol til behandling af glucocerebrosidase-associerede lidelser |
| CN106220718B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP60及其应用 |
| CN106243203B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP70及其应用 |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
| EP3781588B1 (en) | 2018-04-20 | 2024-10-30 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| CN112585130A (zh) | 2018-06-27 | 2021-03-30 | 蛋白质平衡治疗股份有限公司 | 蛋白酶体活性增强化合物 |
| BR112020026580A2 (pt) | 2018-06-27 | 2021-03-23 | Proteostasis Therapeutics, Inc. (Fem) | Compostos, composição farmacêutica e métodos para tratar um paciente |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| KR20230128462A (ko) | 2020-11-19 | 2023-09-05 | 제브라 덴마크 에이/에스 | 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정 |
| CN114046596B (zh) * | 2021-11-17 | 2022-09-23 | 重庆大学 | 基于trp生化指标检测的室内空气质量控制系统及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5348945A (en) * | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
| CA2095855C (en) * | 1990-11-08 | 2003-04-29 | Graham A.W. Rook | Mycobacterium as adjuvant for antigens |
| GB9211736D0 (en) * | 1992-06-03 | 1992-07-15 | Univ Cardiff | Allergic treatment |
| JP4484969B2 (ja) * | 1996-11-26 | 2010-06-16 | ヌベンタ バイオファーマスティカル コーポレイション | ストレスタンパク質を含む組成物を使用する免疫応答 |
-
1999
- 1999-01-22 CZ CZ20002669A patent/CZ20002669A3/cs unknown
- 1999-01-22 ZA ZA9900499A patent/ZA99499B/xx unknown
- 1999-01-22 BR BR9907228-9A patent/BR9907228A/pt not_active IP Right Cessation
- 1999-01-22 CN CN99804346A patent/CN1324243A/zh active Pending
- 1999-01-22 TR TR2000/02973T patent/TR200002973T2/xx unknown
- 1999-01-22 EP EP99903321A patent/EP1049483A1/en not_active Withdrawn
- 1999-01-22 WO PCT/US1999/001421 patent/WO1999037319A1/en not_active Ceased
- 1999-01-22 HU HU0100241A patent/HUP0100241A2/hu unknown
- 1999-01-22 JP JP2000528300A patent/JP2002509074A/ja active Pending
- 1999-01-22 AU AU23374/99A patent/AU2337499A/en not_active Abandoned
- 1999-01-22 IL IL13740499A patent/IL137404A0/xx unknown
- 1999-01-22 KR KR1020007008033A patent/KR20010040389A/ko not_active Withdrawn
- 1999-01-22 PL PL99342166A patent/PL342166A1/xx not_active Application Discontinuation
- 1999-01-22 CA CA002318263A patent/CA2318263A1/en not_active Abandoned
-
2000
- 2000-07-21 NO NO20003775A patent/NO20003775L/no not_active Application Discontinuation
-
2001
- 2001-08-17 US US09/932,483 patent/US20020006410A1/en not_active Abandoned
-
2006
- 2006-09-25 US US11/534,782 patent/US20070179087A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1324243A (zh) | 2001-11-28 |
| HUP0100241A2 (hu) | 2001-06-28 |
| ZA99499B (en) | 1999-07-22 |
| US20070179087A1 (en) | 2007-08-02 |
| EP1049483A1 (en) | 2000-11-08 |
| CA2318263A1 (en) | 1999-07-29 |
| IL137404A0 (en) | 2001-07-24 |
| NO20003775L (no) | 2000-09-22 |
| AU2337499A (en) | 1999-08-09 |
| CZ20002669A3 (cs) | 2001-11-14 |
| WO1999037319A1 (en) | 1999-07-29 |
| PL342166A1 (en) | 2001-05-21 |
| JP2002509074A (ja) | 2002-03-26 |
| KR20010040389A (ko) | 2001-05-15 |
| BR9907228A (pt) | 2000-10-24 |
| US20020006410A1 (en) | 2002-01-17 |
| NO20003775D0 (no) | 2000-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002973T2 (tr) | Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi | |
| FI963218A0 (fi) | Mykofenolihapon 5-substituoidut johdannaiset | |
| DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
| ATE461938T1 (de) | Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung | |
| DE69938302D1 (de) | Neisseria meningitidis antigene und zusammenstellungen | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
| ATE211467T1 (de) | 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung | |
| EP1576137A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES | |
| DK0745075T3 (da) | 6-Substituerede mycophenolsyrederivater med immunsuppressiv virkning | |
| TR200002284T2 (tr) | Mage ailesinden tümör ile ilgili tümör türevleri | |
| NO20001240D0 (no) | Kay-A immunsystemprotein | |
| ES2192839T3 (es) | Timosina beta 4 oxidada. | |
| DK0876398T3 (da) | Induktion af immunrespons med ønskede determinanter | |
| DE60109430D1 (de) | An entzündlichen darmerkrankungen beteiligte gene und deren verwendung | |
| TR200001948T2 (tr) | Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar. | |
| ATE249835T1 (de) | Immunoregulator | |
| EP1578373A4 (en) | NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM | |
| DE69928523D1 (de) | Verotoxin b untereinheit zur immunisierunug | |
| ITMI942238A0 (it) | Anticorpi naturali contro proteine allogeniche e xenogeniche e me- todi per la loro determinazione | |
| NO20011412D0 (no) | FremgangsmÕter for nedmodulering av immunresponsen til terapeutiske proteiner | |
| EP1228082A4 (en) | HUMAN SECRETED PROTEINS 29 | |
| NO881942D0 (no) | Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten. | |
| EP1257298A4 (en) | KOSMID-DNA CONSTRUCTS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DE69932711D1 (de) | Proteine mit modulatorischer aktivität gegenüber dem immunsystem und behandlungen für immunologische erkrankungen |